Fu Tao's Form 4 filing
Zai Lab Ltd (ZLAB) · filed Jul 19, 2021
- Accession no.
- 0001567619-21-013659
- Filed
- Jul 19, 2021
- Trade date
- Jul 15, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.73M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fu TaoCIK 0001644888 | Director, Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Ordinary Shares | MOption exerciseAcquired | +10,000 | $18.92 | +$189,200 | 217,000 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −2,333 | $170.30F2 | −$397,309.9 | 214,667 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −1,000 | $171.36F3 | −$171,360 | 213,667 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −21 | $171.89 | −$3,609.69 | 213,646 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −3,281 | $173.56F4 | −$569,450.36 | 210,365 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −3,265 | $174.26F5 | −$568,958.9 | 207,100 | Direct | |
| Jul 15, 2021 | Ordinary Shares | SSaleDisposed | −100 | $175.00F2 | −$17,500 | 207,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Ordinary Shares | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 440,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects a weighted average sale price of $170.30 per share, at prices ranging from $169.81 to $170.64 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
Reflects a weighted average sale price of $171.36 per share, at prices ranging from $170.89 to $171.88 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects a weighted average sale price of $173.56 per share, at prices ranging from $172.94 to $173.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects a weighted average sale price of $174.26 per share, at prices ranging from $173.94 to $174.80 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.